EP0746361A1 - Enteral feeding device - Google Patents
Enteral feeding deviceInfo
- Publication number
- EP0746361A1 EP0746361A1 EP94916527A EP94916527A EP0746361A1 EP 0746361 A1 EP0746361 A1 EP 0746361A1 EP 94916527 A EP94916527 A EP 94916527A EP 94916527 A EP94916527 A EP 94916527A EP 0746361 A1 EP0746361 A1 EP 0746361A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- tube
- tubes
- feeding
- coated
- gastrostomy
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- -1 poly(p-xylene) Polymers 0.000 claims abstract description 28
- 229920000642 polymer Polymers 0.000 claims abstract description 18
- 210000001035 gastrointestinal tract Anatomy 0.000 claims abstract description 9
- 235000016709 nutrition Nutrition 0.000 claims description 23
- 210000002784 stomach Anatomy 0.000 claims description 17
- 239000012530 fluid Substances 0.000 claims description 10
- 210000000936 intestine Anatomy 0.000 claims description 10
- 239000007788 liquid Substances 0.000 claims description 10
- 241000124008 Mammalia Species 0.000 claims description 7
- 229920002635 polyurethane Polymers 0.000 claims description 4
- 239000004814 polyurethane Substances 0.000 claims description 4
- 239000004945 silicone rubber Substances 0.000 claims description 4
- 229920002529 medical grade silicone Polymers 0.000 claims description 2
- 230000006866 deterioration Effects 0.000 abstract description 2
- 230000035611 feeding Effects 0.000 description 47
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 37
- 229920000052 poly(p-xylylene) Polymers 0.000 description 20
- 239000000047 product Substances 0.000 description 17
- 238000012360 testing method Methods 0.000 description 14
- 230000015556 catabolic process Effects 0.000 description 13
- 230000035515 penetration Effects 0.000 description 13
- URLKBWYHVLBVBO-UHFFFAOYSA-N Para-Xylene Chemical group CC1=CC=C(C)C=C1 URLKBWYHVLBVBO-UHFFFAOYSA-N 0.000 description 12
- 238000006731 degradation reaction Methods 0.000 description 12
- 230000012010 growth Effects 0.000 description 11
- 244000005700 microbiome Species 0.000 description 9
- 241000894006 Bacteria Species 0.000 description 7
- 235000013305 food Nutrition 0.000 description 7
- 238000000034 method Methods 0.000 description 6
- 239000006154 MacConkey agar Substances 0.000 description 5
- 210000003815 abdominal wall Anatomy 0.000 description 5
- 239000006161 blood agar Substances 0.000 description 5
- 239000000463 material Substances 0.000 description 5
- 238000000576 coating method Methods 0.000 description 4
- 238000011109 contamination Methods 0.000 description 4
- 239000002609 medium Substances 0.000 description 4
- 230000000813 microbial effect Effects 0.000 description 4
- 210000001015 abdomen Anatomy 0.000 description 3
- 230000015271 coagulation Effects 0.000 description 3
- 238000005345 coagulation Methods 0.000 description 3
- 239000011248 coating agent Substances 0.000 description 3
- 210000001630 jejunum Anatomy 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- 241000588914 Enterobacter Species 0.000 description 2
- 241000588724 Escherichia coli Species 0.000 description 2
- CEAZRRDELHUEMR-URQXQFDESA-N Gentamicin Chemical compound O1[C@H](C(C)NC)CC[C@@H](N)[C@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](NC)[C@@](C)(O)CO2)O)[C@H](N)C[C@@H]1N CEAZRRDELHUEMR-URQXQFDESA-N 0.000 description 2
- 229930182566 Gentamicin Natural products 0.000 description 2
- 241000607720 Serratia Species 0.000 description 2
- 239000006227 byproduct Substances 0.000 description 2
- 230000008021 deposition Effects 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 210000003238 esophagus Anatomy 0.000 description 2
- 229960002518 gentamicin Drugs 0.000 description 2
- 210000000987 immune system Anatomy 0.000 description 2
- 238000011081 inoculation Methods 0.000 description 2
- 238000002483 medication Methods 0.000 description 2
- 230000002503 metabolic effect Effects 0.000 description 2
- 238000007431 microscopic evaluation Methods 0.000 description 2
- 239000000178 monomer Substances 0.000 description 2
- 210000003928 nasal cavity Anatomy 0.000 description 2
- 229920001296 polysiloxane Polymers 0.000 description 2
- 238000000197 pyrolysis Methods 0.000 description 2
- 229920002379 silicone rubber Polymers 0.000 description 2
- 230000008467 tissue growth Effects 0.000 description 2
- 208000030507 AIDS Diseases 0.000 description 1
- 241000222122 Candida albicans Species 0.000 description 1
- 241000222178 Candida tropicalis Species 0.000 description 1
- 208000017897 Carcinoma of esophagus Diseases 0.000 description 1
- 241000588923 Citrobacter Species 0.000 description 1
- 206010010071 Coma Diseases 0.000 description 1
- 208000028399 Critical Illness Diseases 0.000 description 1
- 208000000461 Esophageal Neoplasms Diseases 0.000 description 1
- 241000192125 Firmicutes Species 0.000 description 1
- 241000588748 Klebsiella Species 0.000 description 1
- CERQOIWHTDAKMF-UHFFFAOYSA-M Methacrylate Chemical compound CC(=C)C([O-])=O CERQOIWHTDAKMF-UHFFFAOYSA-M 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- 239000006159 Sabouraud's agar Substances 0.000 description 1
- AXIKDPDWFVPGOD-UHFFFAOYSA-O [7-(dimethylamino)phenothiazin-3-ylidene]-dimethylazanium;2-(2,4,5,7-tetrabromo-3,6-dihydroxyxanthen-10-ium-9-yl)benzoic acid Chemical compound C1=CC(=[N+](C)C)C=C2SC3=CC(N(C)C)=CC=C3N=C21.OC(=O)C1=CC=CC=C1C1=C(C=C(Br)C(O)=C2Br)C2=[O+]C2=C1C=C(Br)C(O)=C2Br AXIKDPDWFVPGOD-UHFFFAOYSA-O 0.000 description 1
- 241000222126 [Candida] glabrata Species 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 235000019577 caloric intake Nutrition 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 229940095731 candida albicans Drugs 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 230000001010 compromised effect Effects 0.000 description 1
- 239000000356 contaminant Substances 0.000 description 1
- 230000007797 corrosion Effects 0.000 description 1
- 238000005260 corrosion Methods 0.000 description 1
- 239000006059 cover glass Substances 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 238000005137 deposition process Methods 0.000 description 1
- 230000010339 dilation Effects 0.000 description 1
- 239000000539 dimer Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 210000001198 duodenum Anatomy 0.000 description 1
- 238000005538 encapsulation Methods 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 238000011010 flushing procedure Methods 0.000 description 1
- 210000004211 gastric acid Anatomy 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 238000009413 insulation Methods 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 229920000126 latex Polymers 0.000 description 1
- 229920001684 low density polyethylene Polymers 0.000 description 1
- 239000004702 low-density polyethylene Substances 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 229920001179 medium density polyethylene Polymers 0.000 description 1
- 239000004701 medium-density polyethylene Substances 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 230000000877 morphologic effect Effects 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- 230000000399 orthopedic effect Effects 0.000 description 1
- 229920000915 polyvinyl chloride Polymers 0.000 description 1
- 230000002028 premature Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 239000006152 selective media Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 230000009469 supplementation Effects 0.000 description 1
- 238000012956 testing procedure Methods 0.000 description 1
- 230000008733 trauma Effects 0.000 description 1
- 238000009834 vaporization Methods 0.000 description 1
- 230000008016 vaporization Effects 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 230000003442 weekly effect Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L29/00—Materials for catheters, medical tubing, cannulae, or endoscopes or for coating catheters
- A61L29/08—Materials for coatings
- A61L29/085—Macromolecular materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J15/00—Feeding-tubes for therapeutic purposes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J15/00—Feeding-tubes for therapeutic purposes
- A61J15/0026—Parts, details or accessories for feeding-tubes
- A61J15/003—Means for fixing the tube inside the body, e.g. balloons, retaining means
- A61J15/0034—Retainers adjacent to a body opening to prevent that the tube slips through, e.g. bolsters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J15/00—Feeding-tubes for therapeutic purposes
- A61J15/0026—Parts, details or accessories for feeding-tubes
- A61J15/0069—Tubes feeding directly to the intestines, e.g. to the jejunum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/08—Materials for coatings
- A61L31/10—Macromolecular materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J15/00—Feeding-tubes for therapeutic purposes
- A61J15/0003—Nasal or oral feeding-tubes, e.g. tube entering body through nose or mouth
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J15/00—Feeding-tubes for therapeutic purposes
- A61J15/0015—Gastrostomy feeding-tubes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J15/00—Feeding-tubes for therapeutic purposes
- A61J15/0026—Parts, details or accessories for feeding-tubes
- A61J15/003—Means for fixing the tube inside the body, e.g. balloons, retaining means
- A61J15/0034—Retainers adjacent to a body opening to prevent that the tube slips through, e.g. bolsters
- A61J15/0038—Retainers adjacent to a body opening to prevent that the tube slips through, e.g. bolsters expandable, e.g. umbrella type
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J15/00—Feeding-tubes for therapeutic purposes
- A61J15/0026—Parts, details or accessories for feeding-tubes
- A61J15/003—Means for fixing the tube inside the body, e.g. balloons, retaining means
- A61J15/0034—Retainers adjacent to a body opening to prevent that the tube slips through, e.g. bolsters
- A61J15/0038—Retainers adjacent to a body opening to prevent that the tube slips through, e.g. bolsters expandable, e.g. umbrella type
- A61J15/0042—Retainers adjacent to a body opening to prevent that the tube slips through, e.g. bolsters expandable, e.g. umbrella type inflatable
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J15/00—Feeding-tubes for therapeutic purposes
- A61J15/0026—Parts, details or accessories for feeding-tubes
- A61J15/0073—Multi-lumen tubes
Definitions
- the present invention relates generally to a tube for use in the enteral feeding of a nutritional product directly into the gastrointestinal tract, and more particularly to an enteral feeding tube coated with a poly(p- xylene) polymer.
- a first example of a tube for use in the enteral feeding of a liquid nutritional product directly into the gastrointestinal tract is a nasogastric tube, which may extend through a patient's nasal cavity, down the esophagus to the stomach.
- a second example of a tube for use in the enteral feeding of a liquid nutritional product directly into the gastrointestinal tract is a gastrostomy tube which may extend through a patient's abdominal wall and stomach wall for feeding directly into the stomach.
- a third example of a tube for use in the enteral feeding of a liquid nutritional product directly into the gastrointestinal tract is a jejunostomy tube which may extend either through the lumen of a gastrostomy tube and thence into the patient's intestine, or through the patient's abdominal wall and intestinal wall, in either case facilitating feeding directly into the intestine.
- a tube for enteral feeding of a liquid nutritional product directly into the gastrointestinal tract may have to be removed is clogging primarily due to the coagulation of an enteral nutritional food product.
- a second reason is degradation of the tube.
- a patient may accidentally or intentionally remove a feeding tube thus requiring the insertion of a replacement tube. Premature replacement of a feeding tube causes the patient to be subjected to the inconvenience, cost, and retraumatization associated with this procedure.
- a tube for use in enteral feeding directly into the stomach or intestine of a mammal comprising a tubular member having an inner and an outer surface, said inner surface being coated with a substituted and/or unsubstituted poly(p-xylene) polymer.
- the outer surface of the tube is coated with said poly(p-xylene) polymer.
- the present invention provides a tube for enteral feeding directly into the stomach or intestine of a mammal which reduces the problems associated with clogging and with degradation, and lessens the frequency of replacement of enteral tube feeding devices due to these problems.
- Fig. 1 is a perspective view of a gastrostomy tube in accordance with the present invention.
- Fig. 2 is a longitudinal cross sectional view taken on a greatly enlarged scale along line 2-2 of Fig. 1.
- Fig. 3 is a longitudinal cross sectional view similar to Fig. 2, but of a modified embodiment of the invention.
- Fig. 4 is a fragmentary cross-section of a conventional tube following testing over a period of months.
- Fig. 5 is a fragmentary cross-section of a tube in accordance with the present invention along line 5-5 of Fig. 2.
- Fig. 6 is a fragmentary cross-section of a tube in accordance with the present invention along line 6-6 of Fig. 3.
- Fig. 7 is a perspective view of another gastrostomy tube which may be employed in the practice of the present invention.
- Fig. 8 is a diagrammatic representation of a jejunal feeding tube which may be employed in the practice of the present invention.
- Fig. 9 is a diagrammatic representation of a jejunostomy tube which may be employed in the practice of the present invention.
- Fig. 10 is a perspective view of a device for feeding a nutritional product directly into the stomach which may be employed in the practice of the present invention.
- Fig. 11 is a diagramatic representation of a nasogastric tube which may be employed in the practice of the present invention.
- tubes used for the enteral feeding of liquid nutritional products into the stomach or intestine of a mammal such as gastrostomy tubes
- clogging of the tube can be caused by coagulated enteral nutritional formulas, or by crushed medications or other solids introduced into the tube.
- users of such tubes may flush a clogged feeding tube with a fluid, such as water, in an attempt to restore the patency of the lumen. If the flushing is unsuccessful, the tube is generally replaced with a new one. Thus the patient is subjected to the inconvenience, cost and trauma associated with the replacement procedure.
- Enteral feeding tubes are typically comprised of silicone rubber, and microorganisms, such as Candida tropicalis, Candida albicans, Torulopsis glabrata, and others can attach themselves to the surface of the silicone rubber. Under normal patient health conditions, these microorganisms pose no problems. However, in patients whose immune systems may be compromised (for example - cancer or AIDS patients) microorganisms can proliferate internally and the patient cannot fight them with their normal immune systems.
- microorganisms only cause a problem after they have been introduced into a patient's body, but that is more easily done than might be expected.
- skin yeasts can be present on unclean hands, such that hand contact with the food inlet port may accidently introduce yeast into the tube. This accidental contact can occur when cleaning the area, or by improper handling of the tube.
- elastomeric properties e.g. tensile strength, hoop strength, recovery, etc.
- the tube loses its hoop strength resulting in a misshapen tube.
- loss of its elastomeric properties causes the tube to be more easily flattened, especially if nurses attempt to slide crushed medications through the tube by squeezing the tube.
- Figs. 1 and 2 illustrate an example of a gastrostomy tube embodying this invention designated generally by the numeral 10.
- This gastrostomy tube 10 is an example of a replacement, or secondary, gastrostomy tube which is employed when the patient already has a healthy, mature stoma tract.
- the replacement gastrostomy tube may be inserted into the stomach through the stoma following the removal of a primary gastrostomy tube, which will be described later.
- the basic components of this exemplary device are a tubular member 12 having an outer surface wall 13, with the tubular member 12 enclosing a feeding lumen 14 and a fluid flow channel 16.
- the fluid flow channel 16 is also referred to in the trade as a balloon lumen.
- the port housing includes as its primary components, a main food inlet port 20 equipped with a main port closure 21, a Y-port 22 similarly equipped with a Y-port closure 23, and a fluid inlet port 25 equipped with a valve means 26 preferably of the type known as a one-way valve.
- a valve means 26 preferably of the type known as a one-way valve.
- An expandable component member 38 often referred to as a balloon, is secured preferably by means of an adhesive bond 39 to outer surface wall 13.
- a fluid access port 40 extends between the fluid flow channel 16 and the outer surface wall 13 located centrally of the expandable component member. As such, the fluid flow channel is capable of passing fluid from the valve means 26 shown in Fig. 1 into expandable component member 38 so as to permit the expansion of the balloon.
- a retention device 43 is also provided having a triangular configuration and a plurality of vent holes.
- a device for enteral feeding according to the present invention is preferably fabricated from 100% medical grade silicone rubber, with the exception of the coating which is described below and the components of the valve means 26.
- Fig. 2 discloses this invention comprising a layer 50 of a poly(p-xylene) polymer (parylene) on the inner surface of the tubular member.
- a layer 60 of a poly(p-xylene) polymer coats the outer surface of the tubular member.
- Poly(p-xylene) polymers are well known.
- the preferred choice for this invention is the parylene supplied by Specialty Coating Systems (a subsidiary of Union Carbide) of Indianapolis, Indiana. Parylene has been used to coat orthopedic products to render their materials compatible with body tissue, and to serve as a dry film lubricant.
- Patents involving parylene or poly(p-xylene) polymers include U.S. Patent No. 3,826,244 to Salcman et al for Thumbtack Microelectrode and Method of Making Same, and U.S. Patent No. 4,225,647 for Articles Having Thin, Continuous, Impervious Coatings.
- the parylene is coated onto an outer and/or inner wall of a tubular member by a deposition process.
- First the parylene is heated to approximately 150°C at 1 Torr, resulting in conversion to a gaseous dimer.
- the dimeric gas is forced downstream into a pyrolysis zone as the gas pressure in the vaporization zone rises. In the pyrolysis zone the temperature rises to approximately 690°C at 0.5 Torr, thereby splitting the dimeric molecules into highly reactive monomers.
- parylene-N is used.
- the monomer molecules continue to respond to pressure, flowing into the deposition chamber where they disperse, deposit and polymerize into a clear linear film on all surfaces which are exposed to the gas.
- Deposition takes place in a vacuum environment of approximately 0.1 Torr and near ambient temperature (approximately 35°C) . Coating thickness is relatively uniform, with excellent conformity.
- the tubular member has its entire inner surface coated except for portions located within about 1.3 cm (1/2") from the first end and the second end.
- Each of the tubes were contaminated (for purposes of this study) with an enteral nutritional product in which yeasts, isolated from a tube removed from a patient in a clinical environment, were suspended. Re-contamination with yeasts was repeated on a weekly basis for the first several months of the trial. Then, in an attempt to more accurately model a clinical environment, and to hasten the breakdown of the tubes, various bacteria, also isolated from clinical tubes, including Escherichia coli, Enterobacter, Serratia, Citrobacter, Klebsiella, and Pseudo onas were suspended with the yeast in the enteral nutritional product, and recontamination of the tubes was repeated on a daily basis. This occurred approximately four and one-half months after the test began.
- the parylene coated tubes prior to the test appeared to be somewhat less pliable when squeezed than the fresh, uncoated tubes. Meanwhile, the conventional tubes had a soft, rubbery feel. Over the next couple of months, no changes were readily detected. However, in the time period prior to cessation of the study, the conventional tubes began to lose some of their roundness and appeared to be somewhat bumpy. Also, following squeezing of the conventional tubes, the walls did not spring back to their natural round shape as quickly as before. The poly (p-xylene) polymer coated tubes did not experience any noticeable decline with respect to their physical characteristics.
- the second test involved the growing of cultures on various m ia using coagulum from the tubes. This test was performed in order to identify the contaminating microorganisms. Coagulum was plated on blood agar, MacConkey agar and Sabouraud's agar with gentamicin plates. Blood agar medium is a non-selective medium which allows most aerobic organisms to grow. In this study, culture on blood agar medium resulted in the isolation of yeast and diphtheroids. MacConkey agar permits the growth of gram-negative enteric bacteria, but none were isolated following culture, even after inoculation of the enteral nutritional formula therewith. Only yeasts were isolated on the MacConkey agar.
- the Sabouraud's medium with gentamicin permits the growth of yeasts and inhibits the growth of most bacteria. Only yeasts were isolated. Overall, the results of the cultures (shown below in Tables 1 and 2) indicated that each tube (coated and uncoated) contained yeast and gram-positive bacteria, but no gram-negative organisms. Thus the icrobial culture results confirmed the morphological data of the organisms observed in the gram-stained smears of the coagulum. The cultures also corroborated the failure to establish gram-negative bacteria in any of the silicone tubes.
- Tube 4 Yeast - 3 Yeast - 2 Yeast - 3
- the third test involved a longitudinal incision of each of the tube segments.
- the conventional uncoated tubes subjected to this test lost some elasticity and remained open after a longitudinal incision.
- the appearance of the conventional uncoated tubes subjected to this test and then cut longitudinally resembles the look of tubes from clinical sources when cut longitudinally.
- a parylene coated tube subjected to the same testing procedure remained in apposition when a longitudinal cut was made, indicating that the wall of the tube was not weakened.
- the fourth test involved a visual comparison of the interior walls of the tubes. Swabs were used to clean the inner surface of the tubes.
- the inner surfaces of all the conventional uncoated tubes had focal to more generalized yellowish deposits. These were deposits of the coagulated enteral nutritional product, within which were yeasts. In contrast, the parylene coated tubes were free from deposits. The inner surfaces had the same white color that was present prior to the study.
- the fifth test involved the microscopic evaluation of sections of the tubes.
- Cross sections of previously cleaned tubes were immersed in acetone for approximately 2 minutes, air dried, then immersed in Wright stain for 30 seconds to 1 minute. After washing and drying, the sections were placed on a glass slide surrounded by methacrylate polymer mounting fluid and covered with a cover glass.
- the tube degradation was visually assessed. Focal to more generalized areas of penetration by microganisms into the conventional tubes were observed, typically involving 75-85% of the inner surface of the tube. This finding coincided with the depth of penetration often involving up to 20% of the width of the conventional tubes in some areas as shown in Fig. 4, which is a cross sectional representation of the tube degradation 99 which was observed in conventional uncoated tubes.
- Figs. 5 and 6 are representative cross- sections of the lack of degradation which was observed in any of the parylene coated tubes.
- Fig. 5 is a cross-section of the embodiment of Fig. 2 taken along line 5-5 thereof
- Fig. 6 is a cross-section of the embodiment of Fig. 3 taken along line 6-6 thereof.
- Tube 1 80-85% of tube inner surface involved; 10-30% depth of penetration
- Tube 2 80-85% of tube inner surface involved; 10-25% depth of penetration
- Tube 3 80-85% of tube inner surface involved; 10-20% depth of penetration
- Tube 1 No focal or generalized areas involved; no evidence of penetration or growth into the wall; some cracks noted
- Tube 2 No focal or generalized areas involved; no evidence of penetration or growth into the wall; some cracks noted
- Tube 3 No obvious focal or generalized areas involved; one area of possible penetration or growth into the wall; but could be an artifact; some cracks noted
- Tube 4 No focal or generalized areas involved; one area of possible penetration or growth into the wall; but could be an artifact; some cracks noted
- the parylene coated feeding tubes are superior to the feeding tubes conventionally used today.
- the feeding tubes of this invention do not develop deposits on the inner surface associated with conventional enteral feeding tubes. Additionally, there was evidence of penetration of the inner wall in the conventional tubes, and an apparent loss of elasticity.
- the parylene coated tubes were (with the exception of a single focal area in one tube) free of microbial penetration of the inner wall surface. In conclusion, in terms of tube degradation due to microbial contamination, the parylene coated tubes outperformed the conventional uncoated tubes.
- Figs. 7-11 there is shown a variety of additional devices for enteral feeding directly into the gastrointestinal tract of a mammal which may be employed in the practice of the present invention. These devices are only exemplary and one skilled in the art will immediately recognize that a variety of embodiments of such devices are known which could be employed in the practice of the present invention.
- Fig. 7 is a perspective view of a primary gastrostomy tube 100.
- a primary gastrostomy tube of the type shown may be installed, for example, by means of a percutaneous endoscopic gastrostomy (PEG) .
- PEG percutaneous endoscopic gastrostomy
- a gastrostomy tube of the type shown in Fig. 1 may be employed as a primary gastrostomy tube when placed by a laparoscopic gastrostomy procedure.
- a primary gastrostomy tube is a device used for the initial placement in the patient of an enteral feeding tube which passes through the abdominal wall into the stomach.
- One objective of the use of a primary gastrostomy tube is the formation of a healthy, mature stoma tract which may later facilitate the placement of a replacement, or secondary, gastrostomy tube as has already been described herein.
- FIG. 7 an assembly comprising a primary gastrostomy tube 100 and a tapered dilator 101.
- the tubular portion 102 were to be comprised of a material of sufficient rigidity, it could be configured to function as a dilator. However; inasmuch as the preferred materials for the tubular portion 102 are fairly soft and flexible, it is preferred that the dilation of a stoma formed during a PEG procedure is better accomplished by using a tapered dilator 101 of a more rigid material such as a low or medium density polyethylene.
- An internal retaining member 103 is located at the end of the primary gastrostomy tube which will be disposed within a patient's stomach when the tube is in its operative position.
- the end 104 of the tubular member 102 which will be disposed externally of the patient's abdomen is joined to the larger end 105 of the tapered dilator 101 by a means for connecting such as a barbed nylon connector 106.
- a means for connecting such as a barbed nylon connector 106.
- Such a primary gastrostomy tube has been described in U.S. Patent 5,080,650. It is the tubular portion 102 of the primary gastrostomy tube which may advantageously be coated with a substituted and/or unsubstituted poly (p-xylene) polymer in accordance with the present invention.
- a jejunal feeding tube 109 with the primary gastrostomy tube 100 which has been installed with its internal retaining member 103 disposed within the stomach 110 of a patient.
- the excess length of the gastrostomy tube has been cut off to such that about 15 cm of the gastrostomy tube is located exterior of the patient's abdomen.
- Feeding of the patient may then commence by passing a jejunal feeding tube 109 through the gastrostomy tube 100 into the stomach 110, past the pyloris and into the small bowel. Once in the small bowel the jejunal feeding tube 109 passes through the duodenum 111 and preferably terminates in the area of the jejunum 112.
- a jejunal feeding tube may advantageously be coated with a substituted and/or unsubstituted poly (p- xylene) polymer in accordance with the present invention.
- a jejunostomy tube 115 in its operative position extending through the abdominal wall 116 of a patient into the patient's jejunum 117.
- the patient's jejunum is secured against the abdominal wall by retaining devices having an internal T-member 118 secured to an external member 119 by a suture 120.
- the jejunostomy tube 115 is secured by a suitable retaining device 121.
- Located at the external end of the jejunostomy tube is a port 122 for receiving a nutritional product.
- a jejunostomy tube may be installed, for example, using a laparoscopic procedure of the type taught in U.S. Patent 5,151,086.
- the tubular portion of a jejunostomy tube is typically comprised of polyurethane.
- the tubular portion of a jejunostomy tube may advantageously be coated with a substituted and/or unsubstituted poly (p- xylene) polymer in accordance with the present invention.
- FIG. 10 there is shown a perspective view of an example of a type of replacement gastrostomy tube 130 having a tubular portion 131, a stretchable internal retaining portion 132 (which is located inside the stomach when installed) and an external retaining member 133 (which is located adjacent to, and external of the patient's abdomen when installed).
- a stopper member 134 is used to plug the feeding lumen between feedings.
- Such replacement gastrostomy tubes have been marketed by Ross Laboratories, a Division of Abbott Laboratories, Columbus, Ohio, U.S.A.
- the tubular portion of this type of replacement gastrostomy tube may advantageously be coated with a substituted and/or unsubstituted poly (p-xylene) polymer in accordance with the present invention.
- a nasogastric tube 140 which extends through a patient's nasal cavity 141 and esophagus 142 to the stomach 143, and may further extend if desired into the intestine 144 (if placed in the intestine the tube may also be referred to as a nasogastrointestinal tube) .
- a nasogastric tube may be employed in enterally feeding directly into the patient's gastrointestinal tract.
- the tubular portion of a nasogastric tube is typically comprised of polyurethane.
- a nasogastric (or nasogastrointestinal) tube may advantageously be coated with a substituted and/or unsubstit ited poly (p-xylene) polymer in accordance with the present invention.
- the enteral feeding industry has long sought ways to reduce retraumatization due to replacement of feeding tubes. Additionally, the industry has sought ways to minimize the potential for problems due to tube clogging and degradation. This invention solves the long felt need. All the advantages of this invention would be found extremely beneficial by physicians, and more importantly by patients.
- the invention could, for example, take the form of a gastrostomy tube, a replacement gastrostomy tube, a jejunal feeding tube, a nasogastric tube or jejunostomy tube. Additionally the tubes could be of PVC, latex rubber, or polyurethane.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Surgery (AREA)
- Vascular Medicine (AREA)
- Medical Preparation Storing Or Oral Administration Devices (AREA)
- Infusion, Injection, And Reservoir Apparatuses (AREA)
Abstract
An enteral feeding device (10) for feeding directly into the gastrointestinal tract is provided with a tube (12) having an outer (13) and an inner surface, and with the inner surface encompassing a feeding lumen (14) and being coated with a substituted and/or unsubstituted poly(p-xylene) polymer (50) to retard the deterioration and clogging of the device. Examples of such devices are nasogastric tubes, gastrostomy tubes and jejunostomy tubes.
Description
ENTERAL FEEDING DEVICE
TECHNICAL FIELD
The present invention relates generally to a tube for use in the enteral feeding of a nutritional product directly into the gastrointestinal tract, and more particularly to an enteral feeding tube coated with a poly(p- xylene) polymer.
BACKGROUND OF THE INVENTION
Many individuals in health care facilities are able to achieve sufficient caloric intake through eating prepared meals. However, a sizable number of such patients are unable to ingest enough food to meet their bodies1 needs. Examples of these individuals would include burn patients, whose daily caloric needs are often in excess of 5,000 calories; critically ill, weak or comatose patients, who may be unable to chew their food; and patients suffering from cancer of the esophagus, who may be unable to swallow their food. For many of these patients, caloric supplementation through enteral feeding is desired. In response to this problem, liquid nutritional products have been developed for enteral feeding. Enteral feeding may utilize a tube to transport a liquid nutritional product from a container directly into the patient's stomach or intestine.
A first example of a tube for use in the enteral feeding of a liquid nutritional product directly into the gastrointestinal tract is a nasogastric tube, which may extend through a patient's nasal cavity, down the esophagus to the stomach. A second example of a tube for use in the enteral feeding of a liquid nutritional product directly into the gastrointestinal tract is a gastrostomy tube which may extend through a patient's abdominal wall and stomach wall for feeding directly into the stomach. A third example of a
tube for use in the enteral feeding of a liquid nutritional product directly into the gastrointestinal tract is a jejunostomy tube which may extend either through the lumen of a gastrostomy tube and thence into the patient's intestine, or through the patient's abdominal wall and intestinal wall, in either case facilitating feeding directly into the intestine.
One reason why a tube for enteral feeding of a liquid nutritional product directly into the gastrointestinal tract may have to be removed is clogging primarily due to the coagulation of an enteral nutritional food product. A second reason is degradation of the tube. Furthermore, a patient may accidentally or intentionally remove a feeding tube thus requiring the insertion of a replacement tube. Premature replacement of a feeding tube causes the patient to be subjected to the inconvenience, cost, and retraumatization associated with this procedure.
It is thus apparent that the need exists for an improved liquid nutritional feeding tube which reduces degradation and clogging.
There is disclosed herein a tube for use in enteral feeding directly into the stomach or intestine of a mammal comprising a tubular member having an inner and an outer surface, said inner surface being coated with a substituted and/or unsubstituted poly(p-xylene) polymer. In one embodiment of the invention, the outer surface of the tube is coated with said poly(p-xylene) polymer. As used herein and in the claims "parylene" and "poly (p-xylene) polymer" are used interchangeably.
The present invention provides a tube for enteral feeding directly into the stomach or intestine of a mammal which reduces the problems associated with clogging and with degradation, and lessens the frequency of replacement of enteral tube feeding devices due to these problems.
Other aspects and advantages of the invention will be apparent from the following description, the accompanying drawings and the appended claims.
BRIEF DESCRIPTION OF THE DRAWINGS
Fig. 1 is a perspective view of a gastrostomy tube in accordance with the present invention.
Fig. 2 is a longitudinal cross sectional view taken on a greatly enlarged scale along line 2-2 of Fig. 1.
Fig. 3 is a longitudinal cross sectional view similar to Fig. 2, but of a modified embodiment of the invention.
Fig. 4 is a fragmentary cross-section of a conventional tube following testing over a period of months.
Fig. 5 is a fragmentary cross-section of a tube in accordance with the present invention along line 5-5 of Fig. 2.
Fig. 6 is a fragmentary cross-section of a tube in accordance with the present invention along line 6-6 of Fig. 3.
Fig. 7 is a perspective view of another gastrostomy tube which may be employed in the practice of the present invention.
Fig. 8 is a diagrammatic representation of a jejunal feeding tube which may be employed in the practice of the present invention.
Fig. 9 is a diagrammatic representation of a jejunostomy tube which may be employed in the practice of the present invention.
Fig. 10 is a perspective view of a device for feeding a nutritional product directly into the stomach which may be employed in the practice of the present invention.
Fig. 11 is a diagramatic representation of a nasogastric tube which may be employed in the practice of the present invention.
DETAILED DESCRIPTION OF THE INVENTION
In tubes used for the enteral feeding of liquid nutritional products into the stomach or intestine of a mammal such as gastrostomy tubes, clogging of the tube can be caused by coagulated enteral nutritional formulas, or by crushed medications or other solids introduced into the tube. Currently, users of such tubes may flush a clogged feeding tube with a fluid, such as water, in an attempt to restore the patency of the lumen. If the flushing is unsuccessful, the tube is generally replaced with a new one. Thus the patient is subjected to the inconvenience, cost and trauma associated with the replacement procedure.
In tubes used for enteral feeding into the stomach or intestine of a mammal, deterioration also presents a significant problem. Enteral feeding tubes are typically comprised of silicone rubber, and microorganisms, such as Candida tropicalis, Candida albicans, Torulopsis glabrata, and others can attach themselves to the surface of the silicone rubber. Under normal patient health conditions, these microorganisms pose no problems. However, in patients whose immune systems may be compromised (for example - cancer or AIDS patients) microorganisms can proliferate internally and the patient cannot fight them with their normal immune systems.
Of course, microorganisms only cause a problem after they have been introduced into a patient's body, but that is more easily done than might be expected. For example, skin yeasts can be present on unclean hands, such that hand contact with the food inlet port may accidently introduce yeast into the tube. This accidental contact can occur when cleaning the area, or by improper handling of the tube.
Once any of these organisms enters an enteral feeding tube there is the potential for a problem. As
microorganisms attach to a tube wall they give off metabolic byproducts and carbon dioxide as they grow. The metabolic byproducts can degrade the tube wall. Subsequent propagation of the microorganisms into the area weakened by the degradation can cause further degradation of the tube. Sometimes, the growth extends into the wall in an elongated fashion, such that when the growth reaches the outside of the tube, pin hole size apertures are formed, which apertures present the potential for leakage.
This growth of microorganisms and the accompanying degradation of the tube causes the tube to lose its elastomeric properties (e.g. tensile strength, hoop strength, recovery, etc.). As it loses its elastomeric properties, the tube loses its hoop strength resulting in a misshapen tube. Also, loss of its elastomeric properties causes the tube to be more easily flattened, especially if nurses attempt to slide crushed medications through the tube by squeezing the tube.
Additionally, as the microorganisms attach and multiply into the feeding lumen the smooth walls of the lumen become pitted. Then as gastric acid mixes with the protein in the liquid nutritional product coagulation occurs, with this coagulation having an increased tendency to attach to the pitted tube wall. Over time, clogging of the tube COΓ. become a problem. The problem of clogging is so pronounced that it is one of the most frequent complaints by nurses relating to enteral feeding tubes.
Having reference to the drawings, attention is directed first to Figs. 1 and 2 which illustrate an example of a gastrostomy tube embodying this invention designated generally by the numeral 10. This gastrostomy tube 10 is an example of a replacement, or secondary, gastrostomy tube which is employed when the patient already has a healthy, mature stoma tract. The replacement gastrostomy tube may be inserted into the stomach through the stoma following the removal of a primary gastrostomy tube, which will be
described later. The basic components of this exemplary device are a tubular member 12 having an outer surface wall 13, with the tubular member 12 enclosing a feeding lumen 14 and a fluid flow channel 16. The fluid flow channel 16 is also referred to in the trade as a balloon lumen.
At one end end 17 of the tubular member 12 is port housing 18. The port housing includes as its primary components, a main food inlet port 20 equipped with a main port closure 21, a Y-port 22 similarly equipped with a Y-port closure 23, and a fluid inlet port 25 equipped with a valve means 26 preferably of the type known as a one-way valve. At the other end 28 of the flexible tubular member 12 is food outlet port 30. An expandable component member 38, often referred to as a balloon, is secured preferably by means of an adhesive bond 39 to outer surface wall 13. A fluid access port 40 extends between the fluid flow channel 16 and the outer surface wall 13 located centrally of the expandable component member. As such, the fluid flow channel is capable of passing fluid from the valve means 26 shown in Fig. 1 into expandable component member 38 so as to permit the expansion of the balloon.
As can be seen in Fig. 1 a retention device 43 is also provided having a triangular configuration and a plurality of vent holes. A device for enteral feeding according to the present invention is preferably fabricated from 100% medical grade silicone rubber, with the exception of the coating which is described below and the components of the valve means 26.
Fig. 2 discloses this invention comprising a layer 50 of a poly(p-xylene) polymer (parylene) on the inner surface of the tubular member. In another embodiment of the invention shown in Fig. 3, a layer 60 of a poly(p-xylene) polymer coats the outer surface of the tubular member. In all other respects these two embodiments are substantially the same as described above.
Poly(p-xylene) polymers are well known. The preferred choice for this invention is the parylene supplied by Specialty Coating Systems (a subsidiary of Union Carbide) of Indianapolis, Indiana. Parylene has been used to coat orthopedic products to render their materials compatible with body tissue, and to serve as a dry film lubricant. It has also been used as an intimal lining to promote tissue growth and adhesion where it is desired to stimulate tissue growth. Furthermore, it has been used in general insulation resistance via encapsulation to isolate materials and devices from body fluid, moisture, and ior.ic contaminants. Finally, it has been used to coat metal to prevent corrosion.
Patents involving parylene or poly(p-xylene) polymers include U.S. Patent No. 3,826,244 to Salcman et al for Thumbtack Microelectrode and Method of Making Same, and U.S. Patent No. 4,225,647 for Articles Having Thin, Continuous, Impervious Coatings.
The parylene is coated onto an outer and/or inner wall of a tubular member by a deposition process. First the parylene is heated to approximately 150°C at 1 Torr, resulting in conversion to a gaseous dimer. The dimeric gas is forced downstream into a pyrolysis zone as the gas pressure in the vaporization zone rises. In the pyrolysis zone the temperature rises to approximately 690°C at 0.5 Torr, thereby splitting the dimeric molecules into highly reactive monomers. In the preferred embodiment of this invention parylene-N is used.
The monomer molecules continue to respond to pressure, flowing into the deposition chamber where they disperse, deposit and polymerize into a clear linear film on all surfaces which are exposed to the gas. Deposition takes place in a vacuum environment of approximately 0.1 Torr and near ambient temperature (approximately 35°C) . Coating thickness is relatively uniform, with excellent conformity. In this exemplary gastrostomy tube, the tubular member has its entire inner surface coated except for portions located
within about 1.3 cm (1/2") from the first end and the second end.
In order to determine whether the invention as described above really represented a significant advancement over the prior art, a test was conducted comparing a parylene coated tube with an unprotected (uncoated) silicone tube. In actuality, four tubes of each type were used in the comparative study.
Each of the tubes were contaminated (for purposes of this study) with an enteral nutritional product in which yeasts, isolated from a tube removed from a patient in a clinical environment, were suspended. Re-contamination with yeasts was repeated on a weekly basis for the first several months of the trial. Then, in an attempt to more accurately model a clinical environment, and to hasten the breakdown of the tubes, various bacteria, also isolated from clinical tubes, including Escherichia coli, Enterobacter, Serratia, Citrobacter, Klebsiella, and Pseudo onas were suspended with the yeast in the enteral nutritional product, and recontamination of the tubes was repeated on a daily basis. This occurred approximately four and one-half months after the test began. Additionally, 10 ml of fresh enteral nutritional product, with or without organisms, was passed through each tube at least six times per week. Smears were examined periodically to assure the presence of organisms, especially yeasts, in the nutritional product. The test was suspended after approximately five and one-half months.
Physically, the parylene coated tubes prior to the test appeared to be somewhat less pliable when squeezed than the fresh, uncoated tubes. Meanwhile, the conventional tubes had a soft, rubbery feel. Over the next couple of months, no changes were readily detected. However, in the time period prior to cessation of the study, the conventional tubes began to lose some of their roundness and appeared to be somewhat bumpy. Also, following squeezing of the conventional tubes, the walls did not spring back to their natural round shape as
quickly as before. The poly (p-xylene) polymer coated tubes did not experience any noticeable decline with respect to their physical characteristics.
At the conclusion of the study, all of the tubes (coated and uncoated) were cut in two near the mid-point of the tube. Five additional tests were then performed. The first test involved a gram stain of a sample of the coagulated enteral nutritional from the interior of the tube. This examination revealed that the yeast organisms were always present in the coagulum. In addition, small gram-positive rod shaped bacteria were also observed. These presumably resulted from contamination of the orifices of the Y-port used to infuse the enteral nutritional and which came from the environment or the skin.
Additionally, at no time were medium sized gram-negative rods observed in the stained smears. This suggested that contamination with enteric and environmental organisms such as Escherichia coli, Enterobacter, Serratia and related bacteria did not occur, in spite of numerous inoculations with these bacteria.
The second test involved the growing of cultures on various m ia using coagulum from the tubes. This test was performed in order to identify the contaminating microorganisms. Coagulum was plated on blood agar, MacConkey agar and Sabouraud's agar with gentamicin plates. Blood agar medium is a non-selective medium which allows most aerobic organisms to grow. In this study, culture on blood agar medium resulted in the isolation of yeast and diphtheroids. MacConkey agar permits the growth of gram-negative enteric bacteria, but none were isolated following culture, even after inoculation of the enteral nutritional formula therewith. Only yeasts were isolated on the MacConkey agar. The Sabouraud's medium with gentamicin permits the growth of yeasts and inhibits the growth of most bacteria. Only yeasts were isolated.
Overall, the results of the cultures (shown below in Tables 1 and 2) indicated that each tube (coated and uncoated) contained yeast and gram-positive bacteria, but no gram-negative organisms. Thus the icrobial culture results confirmed the morphological data of the organisms observed in the gram-stained smears of the coagulum. The cultures also corroborated the failure to establish gram-negative bacteria in any of the silicone tubes.
TABLE 1 FINAL CULTURE RESULTS OF PARYLENE COATED TUBES
SAMPLE BLOOD AGAR MACCONKEY AGAR SABOURAUD'S
Tube 1 Yeast - 2 Yeast - 2 Yeast - 3
(2 Types) (1 Type) (3 Types)
Diphtheroid - 3
Tube 2 Yeast - 2 Yeast - 2 Yeast - 3
(2 Types) (1 Type) (3 Types)
Diphtheroid - 3
Tube 3 Yeast - 2 Yeast - 2 Yeast - 3
(2 Types) (l Type) (3 Types)
Diphtheroid - 3
Tube 4 Yeast - 3 Yeast - 2 Yeast - 3
(3 Types) (2 Types) (3 Types)
Diphtheroid - 3
1 = light numbers
2 = moderate numbers
3 = heavy numbers
TABLE 2 FINAL CULTURE RESULTS OF UNCOATED TUBES
SAMPLE BLOOD AGAR MACCONKEY AGAR SABOURAUD'S
Tube 1 Yeast - 2 Yeast - 1 Yeast - 1
(3 Types) (1 Type) (1 Type)
Diphtheroid - 2
Tube 2 Yeast - 3 Yeast - 1 Yeast - 1
(3 Types) (1 Type) (1 Type)
Diphtheroid - 3
Tube 3 Yeast - 2 Yeast - 1 Yeast - 1
(3 Types) (2 Types) (3 Types)
Diphtheroid - 2
Tube 4 Yeast - 1 Yeast - 1 Yeast - 1
(3 Types) (2 Types) (3 Types)
Diphtheroid - 3
1 = light numbers
2 = moderate numbers
3 = heavy numbers
The third test involved a longitudinal incision of each of the tube segments. In contrast to new, unused tubes which when cut longitudinally maintained their round shape, the conventional uncoated tubes subjected to this test lost some elasticity and remained open after a longitudinal incision. The appearance of the conventional uncoated tubes subjected to this test and then cut longitudinally resembles the look of tubes from clinical sources when cut longitudinally. A parylene coated tube subjected to the same testing procedure remained in apposition when a longitudinal cut was made, indicating that the wall of the tube was not weakened.
The fourth test involved a visual comparison of the interior walls of the tubes. Swabs were used to clean the inner surface of the tubes. The inner surfaces of all the conventional uncoated tubes had focal to more generalized yellowish deposits. These were deposits of the coagulated enteral nutritional product, within which were yeasts. In contrast, the parylene coated tubes were free from deposits. The inner surfaces had the same white color that was present prior to the study.
The fifth test involved the microscopic evaluation of sections of the tubes. Cross sections of previously cleaned tubes were immersed in acetone for approximately 2 minutes, air dried, then immersed in Wright stain for 30 seconds to 1 minute. After washing and drying, the sections were placed on a glass slide surrounded by methacrylate polymer mounting fluid and covered with a cover glass. The tube degradation was visually assessed. Focal to more generalized areas of penetration by microganisms into the conventional tubes were observed, typically involving 75-85% of the inner surface of the tube. This finding coincided with the depth of penetration often involving up to 20% of the width of the conventional tubes in some areas as shown in Fig. 4, which is a cross sectional representation of the tube
degradation 99 which was observed in conventional uncoated tubes. Meanwhile, with respect to the parylene coated tubes of this invention, Figs. 5 and 6 are representative cross- sections of the lack of degradation which was observed in any of the parylene coated tubes. (Fig. 5 is a cross-section of the embodiment of Fig. 2 taken along line 5-5 thereof, and Fig. 6 is a cross-section of the embodiment of Fig. 3 taken along line 6-6 thereof.
As can be observed in Fig. 4, there has been microbial growth 99, and especially microbial penetration into the uncoated tube. In addition to Fig. 4 which is a pictorial representation of tube degradation, the results are also set forth in Table 3.
TABLE 3
MICROSCOPIC EVALUATION OF UNCOATED AND PARYLENE COATED TUBES
UNCOATED
Tube 1 - 80-85% of tube inner surface involved; 10-30% depth of penetration
Tube 2 - 80-85% of tube inner surface involved; 10-25% depth of penetration
Tube 3 - 80-85% of tube inner surface involved; 10-20% depth of penetration
Tube 4 - 75% of tube inner surface involved; 10-30% depth of penetration
PARYLENE COATED
Tube 1 - No focal or generalized areas involved; no evidence of penetration or growth into the wall; some cracks noted
Tube 2 - No focal or generalized areas involved; no evidence of penetration or growth into the wall; some cracks noted
Tube 3 - No obvious focal or generalized areas involved; one area of possible penetration or growth into the wall; but could be an artifact; some cracks noted
Tube 4 - No focal or generalized areas involved; one area of possible penetration or growth into the wall; but could be an artifact; some cracks noted
Thus it can be appreciated that the parylene coated feeding tubes are superior to the feeding tubes conventionally used today. The feeding tubes of this invention do not develop deposits on the inner surface associated with conventional enteral feeding tubes. Additionally, there was evidence of penetration of the inner wall in the conventional tubes, and an apparent loss of elasticity. In contrast, the parylene coated tubes were (with the exception of a single focal area in one tube) free of microbial penetration of the inner wall surface. In conclusion, in terms of tube degradation due to microbial contamination, the parylene coated tubes outperformed the conventional uncoated tubes.
Referring now to Figs. 7-11 there is shown a variety of additional devices for enteral feeding directly into the gastrointestinal tract of a mammal which may be employed in the practice of the present invention. These devices are only exemplary and one skilled in the art will immediately recognize that a variety of embodiments of such devices are known which could be employed in the practice of the present invention.
Fig. 7 is a perspective view of a primary gastrostomy tube 100. A primary gastrostomy tube of the type shown may be installed, for example, by means of a percutaneous endoscopic gastrostomy (PEG) . (A gastrostomy tube of the type shown in Fig. 1 may be employed as a primary gastrostomy tube when placed by a laparoscopic gastrostomy procedure.) A primary gastrostomy tube is a device used for the initial placement in the patient of an enteral feeding tube which passes through the abdominal wall into the stomach. One objective of the use of a primary gastrostomy tube is the formation of a healthy, mature stoma tract which may later facilitate the placement of a replacement, or
secondary, gastrostomy tube as has already been described herein.
There is shown in Fig. 7 an assembly comprising a primary gastrostomy tube 100 and a tapered dilator 101. If the tubular portion 102 were to be comprised of a material of sufficient rigidity, it could be configured to function as a dilator. However; inasmuch as the preferred materials for the tubular portion 102 are fairly soft and flexible, it is preferred that the dilation of a stoma formed during a PEG procedure is better accomplished by using a tapered dilator 101 of a more rigid material such as a low or medium density polyethylene. An internal retaining member 103 is located at the end of the primary gastrostomy tube which will be disposed within a patient's stomach when the tube is in its operative position. The end 104 of the tubular member 102 which will be disposed externally of the patient's abdomen is joined to the larger end 105 of the tapered dilator 101 by a means for connecting such as a barbed nylon connector 106. Such a primary gastrostomy tube has been described in U.S. Patent 5,080,650. It is the tubular portion 102 of the primary gastrostomy tube which may advantageously be coated with a substituted and/or unsubstituted poly (p-xylene) polymer in accordance with the present invention.
Referring next to Fig. 8 there is shown the use of a jejunal feeding tube 109 with the primary gastrostomy tube 100 which has been installed with its internal retaining member 103 disposed within the stomach 110 of a patient. In this example the excess length of the gastrostomy tube has been cut off to such that about 15 cm of the gastrostomy tube is located exterior of the patient's abdomen. Feeding of the patient may then commence by passing a jejunal feeding tube 109 through the gastrostomy tube 100 into the stomach 110, past the pyloris and into the small bowel. Once in the small bowel the jejunal feeding tube 109 passes through the duodenum 111 and preferably terminates in the area of the jejunum 112. Feeding of the patient can thereafter be
accomplished using procedures that are well known in the medical arts. A jejunal feeding tube may advantageously be coated with a substituted and/or unsubstituted poly (p- xylene) polymer in accordance with the present invention.
Referring next to Fig. 9 there is shown a jejunostomy tube 115 in its operative position extending through the abdominal wall 116 of a patient into the patient's jejunum 117. The patient's jejunum is secured against the abdominal wall by retaining devices having an internal T-member 118 secured to an external member 119 by a suture 120. The jejunostomy tube 115 is secured by a suitable retaining device 121. Located at the external end of the jejunostomy tube is a port 122 for receiving a nutritional product. A jejunostomy tube may be installed, for example, using a laparoscopic procedure of the type taught in U.S. Patent 5,151,086. The tubular portion of a jejunostomy tube is typically comprised of polyurethane. The tubular portion of a jejunostomy tube may advantageously be coated with a substituted and/or unsubstituted poly (p- xylene) polymer in accordance with the present invention.
Referring next to Fig. 10 there is shown a perspective view of an example of a type of replacement gastrostomy tube 130 having a tubular portion 131, a stretchable internal retaining portion 132 (which is located inside the stomach when installed) and an external retaining member 133 (which is located adjacent to, and external of the patient's abdomen when installed). A stopper member 134 is used to plug the feeding lumen between feedings. Such replacement gastrostomy tubes have been marketed by Ross Laboratories, a Division of Abbott Laboratories, Columbus, Ohio, U.S.A. The tubular portion of this type of replacement gastrostomy tube may advantageously be coated with a substituted and/or unsubstituted poly (p-xylene) polymer in accordance with the present invention.
Referring next to Fig. 11 there is shown a diagrammatic representation of a nasogastric tube 140 which
extends through a patient's nasal cavity 141 and esophagus 142 to the stomach 143, and may further extend if desired into the intestine 144 (if placed in the intestine the tube may also be referred to as a nasogastrointestinal tube) . Such a tube may be employed in enterally feeding directly into the patient's gastrointestinal tract. The tubular portion of a nasogastric tube is typically comprised of polyurethane. A nasogastric (or nasogastrointestinal) tube may advantageously be coated with a substituted and/or unsubstit ited poly (p-xylene) polymer in accordance with the present invention.
INDUSTRIAL APPLICABILITY
On any given day, thousands of persons are being tube fed. The enteral feeding industry has long sought ways to reduce retraumatization due to replacement of feeding tubes. Additionally, the industry has sought ways to minimize the potential for problems due to tube clogging and degradation. This invention solves the long felt need. All the advantages of this invention would be found extremely beneficial by physicians, and more importantly by patients. The invention could, for example, take the form of a gastrostomy tube, a replacement gastrostomy tube, a jejunal feeding tube, a nasogastric tube or jejunostomy tube. Additionally the tubes could be of PVC, latex rubber, or polyurethane.
While the form of the devices herein described constitute a preferred embodiment of this invention, it is to be understood that the invention is not limited to these precise forms of devices and that changes may be made therein without departing from the scope of the invention which is defined in the appended claims.
Claims
1. A device for enteral feeding directly into the gastrointestinal tract of a mammal comprising a tubular member having an outer and an inner surface, said inner surface encompassing a feeding lumen, and at least a portion of said inner surface being coated with a substituted and/or unsubstituted poly(p-xylene) polymer.
2. A device according to claim 1 wherein said tubular member comprises medical grade silicone rubber.
3. A device according to claim 1 wherein at least a portion said outer surface is coated with said poly(p-xylene) polymer.
4. A device according to claim 1 further comprising a fluid inlet port housing for receiving a liquid nutritional product.
5. A device according to claim 1 wherein said tubular member has a first and a second end, said inner surface being continuously coated from about said first end to said second end.
6. A device for enteral feeding directly into the stomach or intestine of a mammal according to claim 1 wherein the tubular member comprises polyurethane and said device is a nasogastric tube.
7. A device according to any one of claims 1 through 5 wherein said device is a nasogastric tube.
8. A device according to any one of claims 1 through 5 wherein said device is a gastrostomy tube.
9. A device according to any one of claims 1 through 5 wherein said device is a jejunostomy tube.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US103012 | 1979-12-13 | ||
US10301293A | 1993-08-05 | 1993-08-05 | |
PCT/US1994/003997 WO1995004564A1 (en) | 1993-08-05 | 1994-04-12 | Enteral feeding device |
Publications (1)
Publication Number | Publication Date |
---|---|
EP0746361A1 true EP0746361A1 (en) | 1996-12-11 |
Family
ID=22292888
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP94916527A Withdrawn EP0746361A1 (en) | 1993-08-05 | 1994-04-12 | Enteral feeding device |
Country Status (2)
Country | Link |
---|---|
EP (1) | EP0746361A1 (en) |
WO (1) | WO1995004564A1 (en) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2478297T3 (en) * | 2001-01-24 | 2014-07-21 | Becton Dickinson And Company | Partition with a lubricating coating |
DE10131152B4 (en) * | 2001-04-30 | 2004-05-27 | Nutricia Healthcare S.A. | Medical balloon button system |
US7611502B2 (en) | 2005-10-20 | 2009-11-03 | Covidien Ag | Connector for enteral fluid delivery set |
EP1935355B1 (en) * | 2006-12-11 | 2015-12-02 | N.V. Nutricia | Tube for enteral nutrition |
US8128599B2 (en) | 2007-07-20 | 2012-03-06 | Tyco Healthcare Group Lp | Lubricious coatings |
US9283151B2 (en) | 2009-10-23 | 2016-03-15 | Louis O. Porreca, JR. | Enteral feeding tube having unclogging lumen |
US11801204B2 (en) | 2018-03-09 | 2023-10-31 | Connecticut Children's Medical Center | Nasogastric device and method |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4863424A (en) * | 1983-11-18 | 1989-09-05 | Blake Joseph W Iii | Tubular medical device and method of making and using the same |
US4668225A (en) * | 1985-12-23 | 1987-05-26 | Superior Healthcare Group, Inc. | Gastrostomy tube and gastrostomy-jejunal feeding tube combination |
US4698056A (en) * | 1986-03-21 | 1987-10-06 | Medi-Tech, Inc. | Enteric feeding device |
US5032113A (en) * | 1989-04-13 | 1991-07-16 | Scimed Life Systems, Inc. | Innerless catheter |
-
1994
- 1994-04-12 WO PCT/US1994/003997 patent/WO1995004564A1/en not_active Application Discontinuation
- 1994-04-12 EP EP94916527A patent/EP0746361A1/en not_active Withdrawn
Non-Patent Citations (1)
Title |
---|
See references of WO9504564A1 * |
Also Published As
Publication number | Publication date |
---|---|
WO1995004564A1 (en) | 1995-02-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU780339B2 (en) | Silicone elastomer material for use with enteric feeding device | |
Baskin | Acute complications associated with bedside placement of feeding tubes | |
CA2229521A1 (en) | Article with antimicrobial coating, its production and use | |
Berkovits et al. | Caustic injury of the oesophagus. Sixteen years experience, and introduction of a new model oesophageal stent | |
EP0287998A3 (en) | Gastric duodenal jejunal catheter for enteral percutaneous feeding | |
EP2468319A1 (en) | New nanoproduct useful in prophilaxis, diagnostics and medical and veterinary treatment | |
JPH04303461A (en) | Gastrostomic formation tube | |
CH617856A5 (en) | ||
CA2007118C (en) | Stoma measuring device | |
Challacombe et al. | Bacterial microflora of the upper gastrointestinal tract in infants without diarrhoea | |
EP0746361A1 (en) | Enteral feeding device | |
Kohn et al. | Enteral nutrition: potential complications and patient monitoring | |
Welch et al. | Comparison of four bedside indicators used to predict duodenal feeding tube placement with radiography | |
JP2008006006A (en) | Tube indwelling in living body | |
Qureshi et al. | Trichobezoar–a condition to think of in case of mobile abdominal mass | |
Gentile et al. | Are specialized endotracheal tubes and heat-and-moisture exchangers cost-effective in preventing ventilator associated pneumonia? | |
EP1729715A1 (en) | Delivery devices and methods of delivering liquids and nutrition to patients | |
Adegboye et al. | Transhiatal esophagectomy in children with corrosive esophageal stricture | |
Yadav et al. | Clean intermittent catheterisation for the neuropathic bladder | |
Kalambaheti et al. | Role of bile in non-specific defence mechanisms of the gut. | |
Binder et al. | Experience with silicone rubber-coated Foley urethral catheters | |
Wirth et al. | Necrotizing Candida infection after percutaneous endoscopic gastrostomy: a fatal and rare complication | |
Roudaut | Residues of aminoglycoside antibiotics in eggs after medication of laying hens | |
Horwood | A literature review of recent advances in enteral feeding and the increased understanding of the gut | |
Teoh et al. | Bacteraemia following percutaneous dilational tracheostomy |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 19960514 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU NL PT SE |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 19971101 |